tiprankstipranks
Advertisement
Advertisement

NERV Stock Latest News

Minerva Neurosciences Updates Governance Following 2026 Shareholder Meeting
Company AnnouncementsMinerva Neurosciences Updates Governance Following 2026 Shareholder Meeting
5h ago
8K
NERV
Minerva Neurosciences Launches ATM Offering to Fund Trial
PremiumCompany Announcements
Minerva Neurosciences Launches ATM Offering to Fund Trial
8d ago
8K
NERV
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
PremiumCompany Announcements
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
20d ago
NERV
Tsao Maintains Hold on Minerva as Roluperidone Phase 3 Progress Balances Rising Losses; $7 Price Target Reaffirmed
PremiumRatings
Tsao Maintains Hold on Minerva as Roluperidone Phase 3 Progress Balances Rising Losses; $7 Price Target Reaffirmed
25d ago
NERV
NERV Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NERV Earnings this Week: How Will it Perform?
1M ago
NERV
Minerva initiated with an Outperform at Citizens
PremiumThe FlyMinerva initiated with an Outperform at Citizens
2M ago
NERV
Minerva Neurosciences Sets 2026 Annual Shareholder Meeting Timeline
Premium
Company Announcements
Minerva Neurosciences Sets 2026 Annual Shareholder Meeting Timeline
2M ago
8K
NERV
Minerva Neurosciences Appoints New Chief Business Officer, Counsel
Premium
Company Announcements
Minerva Neurosciences Appoints New Chief Business Officer, Counsel
2M ago
8K
NERV
Minerva appoints Jim O’Connor as chief business officer
PremiumThe Fly
Minerva appoints Jim O’Connor as chief business officer
2M ago
NERV
Minerva screens first patient in roluperidone trial
PremiumThe Fly
Minerva screens first patient in roluperidone trial
2M ago
NERV
Why Is the VTI ETF Down Today? Daily Snapshot – 3/12/26
PremiumMarket News
Why Is the VTI ETF Down Today? Daily Snapshot – 3/12/26
3M ago
MU
MSS
Minerva price target raised to $7 from $4 at H.C. Wainwright
PremiumThe Fly
Minerva price target raised to $7 from $4 at H.C. Wainwright
3M ago
NERV
Minerva Neurosciences Warns of Major Dilution Risk From Preferred Stock Conversions and Warrant Exercises
PremiumCompany AnnouncementsMinerva Neurosciences Warns of Major Dilution Risk From Preferred Stock Conversions and Warrant Exercises
3M ago
NERV
Minerva files $200M mixed securities shelf
Premium
The Fly
Minerva files $200M mixed securities shelf
3M ago
NERV
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
3M ago
IPI
MSS
Minerva reports Q4 adjusted EPS (64c) vs. (53c) last year
PremiumThe Fly
Minerva reports Q4 adjusted EPS (64c) vs. (53c) last year
3M ago
NERV
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
3M ago
IPI
MSS
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/9/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/9/26
3M ago
IPI
MSS
VTI ETF Adds $1B in Net Flows — Daily Snapshot, 3/6/26
PremiumMarket News
VTI ETF Adds $1B in Net Flows — Daily Snapshot, 3/6/26
3M ago
IPI
MSS
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/5/26
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—3/5/26
3M ago
MSS
VTI
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/4/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/4/26
3M ago
L
IPI
Why Is the VTI ETF Down Today? Daily Snapshot – 3/3/26
Premium
Market News
Why Is the VTI ETF Down Today? Daily Snapshot – 3/3/26
3M ago
L
MSS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >